CME Group Sees Unusually Large Options Volume (NASDAQ:CME)

CME Group Inc. (NASDAQ:CME) saw unusually large options trading activity on Wednesday. Stock traders acquired 8,099 call options on the stock. This is an increase of approximately 129% compared to the average daily volume of 3,537 call options.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CME. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target for the company in a report on Thursday, June 18th. Morgan Stanley decreased their price objective on shares of CME Group from $353.00 to $324.00 and set an “overweight” rating for the company in a report on Friday, July 10th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and increased their target price for the stock from $316.00 to $323.00 in a report on Thursday, June 11th. Finally, Piper Sandler reduced their price target on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 15th. Twelve equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $292.12.

CME Group Stock Performance

Shares of NASDAQ:CME traded up $14.17 on Wednesday, hitting $251.55. The company’s stock had a trading volume of 1,633,443 shares, compared to its average volume of 2,759,275. The company has a market capitalization of $91.15 billion, a price-to-earnings ratio of 21.49, a price-to-earnings-growth ratio of 3.05 and a beta of 0.25. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a 12 month low of $218.31 and a 12 month high of $329.16. The stock’s 50-day moving average is $256.83 and its two-hundred day moving average is $281.68.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period in the previous year, the business earned $2.96 earnings per share. The company’s revenue was up .8% on a year-over-year basis. On average, equities research analysts forecast that CME Group will post 12.18 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s payout ratio is currently 44.37%.

Insider Activity

In related news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares of the company’s stock, valued at $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the sale, the chief executive officer owned 55,630 shares in the company, valued at $16,606,111.30. The trade was a 38.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Asset Dedication LLC lifted its stake in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 37 shares in the last quarter. Whipplewood Advisors LLC grew its holdings in shares of CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after buying an additional 83 shares in the last quarter. FNY Investment Advisers LLC acquired a new position in CME Group during the fourth quarter valued at $27,000. Elkhorn Partners Limited Partnership acquired a new position in CME Group during the fourth quarter valued at $27,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in shares of CME Group in the fourth quarter worth approximately $28,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group beat Q2 expectations, reporting adjusted EPS of $2.99 versus estimates around $2.91-$2.94 and revenue of about $1.71 billion, slightly above forecasts. CME GROUP ($CME) Releases Q2 2026 Earnings
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, reinforcing bullish sentiment. CME Group jumps after Q2 earnings beat and strong trading activity
• Positive Sentiment: Trading activity remained robust, with second-quarter average daily volume of 29.8 million contracts and record market data revenue of $238 million, suggesting strong demand for hedging and market access. CME Group jumps after Q2 earnings beat and strong trading activity
• Neutral Sentiment: Unusually heavy options activity was also reported, with investors buying 8,099 call options, about 129% above normal, which signals increased speculation and interest in further upside. CME stock is up 7% today. Here’s what we see in our data.
• Neutral Sentiment: Analysts continue to view CME favorably overall, with recent price targets still clustering well above the current share price, though a few firms have trimmed targets recently. $CME stock is up 7% today. Here’s what we see in our data.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.